**Background**
Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality worldwide. Among the various enzymatic targets involved in the progression of these conditions, chymase—a serine protease primarily expressed in mast cells—plays a critical role. Chymase is involved in the conversion of angiotensin I to angiotensin II, the degradation of extracellular matrix proteins, and the promotion of inflammation and fibrosis in the heart and blood vessels. Due to its involvement in cardiac remodeling and hypertension, the development of selective chymase inhibitors has become a significant focus for therapeutic intervention in cardiovascular research. In this context, we will introduce a selective chymase inhibitor – 6-Chlorooxindole.
**Definition**
6-Chlorooxindole is a selective chymase inhibitor with an IC50 value of 470 μM. According to the 6-Chlorooxindole description, this compound is utilized as a chemical tool to modulate chymase activity in biological systems.
**Biological Activity**
The 6-Chlorooxindole biological activity is characterized by its high selectivity for its target. Specifically, 6-Chlorooxindole shows >100-fold selectivity for chymase over cathepsin G, which is essential for minimizing off-target effects in experimental models. Based on the 6-Chlorooxindole technical information, the compound possesses a molecular weight of 167.59 and a chemical formula of C8H6ClNO. Research utilizing this inhibitor has focused on the discovery of potent and selective chymase inhibitors through fragment linking strategies, providing a foundation for studying the inhibition of protease-driven cardiovascular pathology. In conclusion, 6-Chlorooxindole is a selective chymase inhibitor that serves as a valuable tool for the study of cardiovascular disease.
Keywords
6-Chlorooxindole, 56341-37-8, Proteasome, chymase inhibitor, cardiovascular disease, Inhibitor, inhibitor, inhibit
References